Pulmonary vasodilator therapy is associated with improved survival in COPD-PH with pulmonary vascular predominance
Abstract Pulmonary hypertension (PH) is a prevalent comorbidity associated with COPD accountable for increased mortality, exacerbation frequency, and progressive clinical course. Studies examining pulmonary vasodilator therapy in COPD-PH have shown mixed results, likely due to the heterogenous natur...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BMC
2026-02-01
|
| 叢編: | BMC Pulmonary Medicine |
| 主題: | |
| 在線閱讀: | https://doi.org/10.1186/s12890-026-04203-4 |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|